Quantitative Analysis of Colistin-Resistant Escherichia coli in Retail Meat from Local Vietnamese Markets
- PMID: 33681373
- PMCID: PMC7910070
- DOI: 10.1155/2021/6678901
Quantitative Analysis of Colistin-Resistant Escherichia coli in Retail Meat from Local Vietnamese Markets
Abstract
The spread of drug-resistant bacteria via food has contributed to the dissemination of resistant bacteria among humans. However, the status of food contamination with resistant bacteria, particularly the quantitative level of resistant bacteria in food, has not yet been well elucidated. In this study, the abundance of colistin-resistant Escherichia coli in meat samples was quantified to understand the origin of the contamination of meat available in local Vietnamese markets. Fifteen samples each of chicken and pork meat purchased from local Vietnamese markets were assessed for the presence of colistin-resistant E. coli with the mobile colistin resistance gene, mcr. The results showed that 40% (6/15) and 66% (10/15) of the pork and chicken meat samples, respectively, were contaminated with colistin-resistant E. coli. The median quantitative levels of colistin-resistant E. coli in the contaminated pork and chicken samples were 1.8 × 104 and 4.2 × 103 CFU/g, respectively. The results of phylogenetic analysis of isolates from a chicken meat sample showed that the contaminated colistin-resistant E. coli was a mix of multiple phylogenetical clones of bacteria that may have multiplied during sale. This is the first study to quantify the abundance of colistin-resistant E. coli in meat samples.
Copyright © 2021 Thang N. Nguyen et al.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
References
-
- Kasiakou S. K., Michalopoulos A., Soteriades E. S., Samonis G., Sermaides G. J., Falagas M. E. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrobial Agents and Chemotherapy. 2005;49(8):3136–3146. doi: 10.1128/AAC.49.8.3136-3146.2005. - DOI - PMC - PubMed
-
- Catry B., Cavaleri M., Baptiste K., et al. Use of colistin-containing products within the European Union and European economic area (EU/EEA): development of resistance in animals and possible impact on human and animal health. International Journal of Antimicrobial Agents. 2015;46(3):297–306. doi: 10.1016/j.ijantimicag.2015.06.005. - DOI - PubMed
-
- Nakayama T., Jinnai M., Kawahara R., et al. Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam. Tropical Animal Health and Production. 2017;49(1):31–37. doi: 10.1007/s11250-016-1154-y. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
